Recent News Releases

Jan 21, 2020
InMed Expands on Announcement of Cannabinol (CBN) Therapeutic Leadership with New Website Content and CEO Interview

InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing medications targeting diseases with high unmet medical need and...

Jan 20, 2020
InMed First to Advance Cannabinol (CBN) into Therapeutic Clinical Trials

InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing therapeutics targeting diseases with high unmet medical needs,...

Jan 16, 2020
InMed Pharmaceuticals to Attend and Exhibit at EB2020 World Congress

InMed Pharmaceuticals Inc. ("InMed" or "the Company") (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing cannabinoid-based medications targeting diseases with high unmet...

Jan 10, 2020
InMed Announces Election of Directors

InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing cannabinoid-based medications targeting diseases with high unmet...

See All News Releases

Latest Presentation

Unlocking the Potential of Cannabinoid Medicines

January 2020

Download pdf

Letter to Shareholders

Annual Letter to Shareholders 2020

January 17, 2020

Download pdf

Company Fact Sheet

Company Fact Sheet

September, 2019

Download pdf

SEDAR® Filings
Loading data...
Financial Reports

Quarterly and Annual Financial Results

2020

First quarter, 2020 (quarter ended September 30, 2019)

2019

AGM Documents
Fourth quarter, 2019 (full year ended June 30, 2019)
Third quarter, 2019 (quarter ended March 31, 2019)
Second quarter, 2019 (quarter ended December 31, 2018)
First quarter, 2019 (quarter ended September 30, 2018)

2018

AGM Documents
Fourth quarter, 2018 (full year ended June 30, 2018)
Third quarter, 2018 (quarter ended March 31, 2018)
Second quarter, 2018 (quarter ended December 31, 2017)
First quarter, 2018 (quarter ended September 30, 2017)

2017

Fourth quarter, 2017 (full year ended June 30, 2017)
Third quarter, 2017 (quarter ended March 31, 2017)
Second quarter, 2017 (quarter ended December 31, 2016)
First quarter, 2017 (quarter ended September 30, 2016)

Stock Performance

OTCQX: IMLFFTSX: IN
-
Loading...
Display Events
 
 
 
 
Chart Style
Currency in USD.
Quote data delayed by at least 15 minutes.
Earnings Events data provided by Wall Street Horizon.
OTCQX: IMLFFTSX: IN
Analyst Coverage
Firm Analyst E-mail Phone
Edison Investment Research Maxim Jacobs MJacobs@edisongroup.com +1 (646) 653-7027
ROTH Capital Partners Jerry Isaacson, Ph.D. jisaacson@roth.com +1 (406) 425-0563